Shannon E Boye Selected Research

Shannon E Boye Research Topics

Disease

7	Leber Congenital Amaurosis 10/2022 - 09/2007
4	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 02/2011
3	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 11/2015
3	Blister (Bulla) 01/2019 - 10/2012
3	Uveitis 02/2016 - 01/2015
2	Blindness (Hysterical Blindness) 10/2022 - 07/2011
2	Hemorrhage 01/2021 - 10/2012
2	Color Vision Defects (Color Blindness) 01/2021 - 01/2016
2	Infections 01/2020 - 04/2011
2	Cone-Rod Dystrophies 01/2019 - 01/2013
2	Inflammation (Inflammations) 05/2015 - 01/2015
2	Retinal Degeneration 07/2011 - 02/2011
1	Retinal cone dystrophy 2 09/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023
1	type 1B Usher syndrome 01/2023
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Hemophilia A (Haemophilia) 01/2021
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Choroideremia 01/2021
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021
1	Canavan Disease (Leukodystrophy, Spongiform) 01/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2021
1	Retinoschisis (Retinoschisis, Juvenile) 01/2021
1	Giant Axonal Neuropathy 01/2021
1	type 1 Amaurosis congenita of Leber 01/2016
1	Atherosclerosis 11/2015
1	congenital stationary Night blindness 11/2015
1	Glaucoma 01/2015
1	Pathologic Processes 01/2015
1	Deaf-Blind Disorders 04/2014
1	Usher Syndromes (Usher Syndrome) 04/2014
1	Retinal Diseases 01/2013

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 09/2023 - 09/2007
3	EndotoxinsIBA 02/2016 - 01/2015
2	guanylate cyclase 1IBA 09/2023 - 01/2019
2	EnzymesIBA 01/2021 - 10/2020
2	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2016 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2014
2	Green Fluorescent ProteinsIBA 01/2015 - 10/2012
2	Tyrosine (L-Tyrosine)FDA Link 04/2011 - 02/2011
1	Myosin VIIaIBA 01/2023
1	Cyclic GMPIBA 10/2022
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 01/2021
1	axicabtagene ciloleucelIBA 01/2021
1	ZolgensmaIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Acetylglucosaminidase (NAGase)IBA 01/2021
1	Adenosine DeaminaseIBA 01/2021
1	tisagenlecleucelIBA 01/2021
1	OligonucleotidesIBA 01/2020
1	InterferonsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 02/2016
1	Hyaluronic Acid (Hyaluronan)IBA 01/2016
1	SaltsIBA 01/2016
1	SolutionsIBA 01/2016
1	OpsinsIBA 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 11/2015
1	LipopolysaccharidesIBA 05/2015
1	Myosins (Myosin)IBA 04/2014
1	c-Mer Tyrosine KinaseIBA 03/2013
1	Guanylate Cyclase-Activating ProteinsIBA 01/2013
1	Neutralizing AntibodiesIBA 10/2012
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2011
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2011

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2011
2	Intravitreal Injections 02/2016 - 01/2015
1	Injections 10/2012